FDA:Jiangsu Bioperfectus Gets Emergency Use Authorization for Coronavirus Test Kit


On June 18th, US Food & Drug Administration granted China’s Jiangsu Bioperfectus Technologies an Emergency Use Authorization for its COVID-19 Coronavirus Real-Time PCR Kit.

The authorization requires that all promotional materials for the polymerase-chain-reaction (PCR) test clearly state that the test has not been cleared or approved by the FDA and must be used only by authorized laboratories.

Further read: